Abstract

3,4-Methylenedioxyamphetamine (MDA) is a potent central nervous system (CNS) stimulant chemically and pharmacologically related to amphetamine and mescaline [1–3] (Fig. 1). The phenylisopropylamine portion of the molecule gives MDA marked sympathomimetic activity similar to amphetamine demonstrated by peripheral vasoconstriction, tachycardia, pupillary dilation, and effects on other smooth muscles. The CNS stimulatory effects of MDA also mimic those of amphetamine, and at high doses convulsions, hyperthermia, and behavioral changes may occur [4]. The 3,4-methyleneoxy group on the phenyl portion of the molecule gives MDA psychopharmacological properties similar to those of mescaline. At an apparent threshold dose of 80 mg, MDA causes marked perceptional distortions that begin approximately 60 min after oral ingestion and last up to 8 h [5]. Subjective effects include intensification of feelings, a facilitation of self-insight, and an overwhelming desire to communicate and relate to other people [6]. At high doses, hallucinations may appear.

Author Information

Poklis, A
St. Louis University School of Medicine, St. Louis, Mo.
Mackell, MA
St. Louis University School of Medicine, St. Louis, Mo.
Drake, WK
St. Louis University School of Medicine, St. Louis, Mo.
Pages: 6
Price: $25.00
Related
Reprints and Permissions
Reprints and copyright permissions can be requested through the
Copyright Clearance Center
Details
Stock #: JFS10791J
ISSN: 0022-1198
DOI: 10.1520/JFS10791J